Insomnia severity was studied in people with post-Covid-19 syndrome who attended the Rehabilitation Department of the Military Central Hospital

Abstract

Background: Worldwide, 10-20% of people infected with Covid-19 develop some kind of syndrome, one of which is insomnia.1 Sleep disorders are widespread in many countries around the world. An online survey of people with postCovid-19 syndrome in several countries found that 78.6% suffered from sleep disturbances.2 In a 2020 study by Enhtsetseg and Timurbaatar, which included 964 people in Mongolia, 27.9% of Mongolians had insomnia, and 42.2% had poor sleep quality. .3 However, no studies have been conducted comparing the frequency of infection among people with Covid-19. Therefore, we aimed to evaluate the severity of insomnia among clients with post-Covid-19 syndrome who are serving in the Rehabilitation Department of the Military Central Hospital and compare it with the frequency of covid-19 infection. In the future, the results of this study are important for optimally selecting and implementing treatment options for the treatment of epidemic-induced insomnia. Aim: To evaluate and compare the severity of insomnia in people with post-Covid-19 syndrome. Materials and Methods: We used a hospital-based single-point research design to randomly select 100 patients with post-Covid-19 syndrome who attended the Rehabilitation Department of the Military Central Hospital between May and September 2022. Insomnia was developed in 1993 by Morin et al. Study data were collected using the Severity Index (ISI), a standardized international questionnaire for assessing the severity of insomnia. Data were analyzed using descriptive statistics and the one-way Anowa test to compare the frequency of covid-19 infection with the severity of insomnia. Results: 61% of the participants in our study were women, and the average age was 50.0±2.8 years. A high rate of insomnia was present in the clients studied, with 40% having moderate insomnia and 55% having clinically severe insomnia. 53.3% of study participants had 1, 30% 2, and 16.6% 3 illnesses due to Covid-19 infection, and multiple illnesses increased the severity of insomnia with statistical significance (p<0.001). Conclusion: In our study, 95% of subjects with post-Covid-19 syndrome had clinically moderate to severe insomnia, and comorbidity with covid-19 increased the severity of insomnia. Further clinical follow-up studies involving people with post-Covid-19 insomnia syndrome are needed.